SARS-CoV-2 3CLpro dimer cleaves TAB1

Stable Identifier
R-HSA-9729704
Type
Reaction [transition]
Species
Homo sapiens
Related Species
Severe acute respiratory syndrome coronavirus 2
Compartment
ReviewStatus
5/5
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout
SARS-CoV-2 nsp5 protease (3CLpro) specifically cleaves TAB1 at two sites and decreases its level in SARS-CoV-2 infected cells. Mutants with inhibited 3CLpro activity show no decrease in TAB1 levels (Moustaqil et al, 2021). Intact TAB1 is part of a complex that regulates the activity of TAK1, a regulator of the NFκB pathway and the signaling through the MAP kinases pathway in response to different stimuli and upon viral and bacterial infections (Dai et al, 2012; Malireddi et al, 2019).
Literature References
PubMed ID Title Journal Year
31850239 ZBP1 and TAK1: Master Regulators of NLRP3 Inflammasome/Pyroptosis, Apoptosis, and Necroptosis (PAN-optosis)

Kesavardhana, S, Malireddi, RKS, Kanneganti, TD

Front Cell Infect Microbiol 2019
22941947 TAK1, more than just innate immunity

Aye Thu, C, Cheung, PC, Xi, J, Liu, XY, Dai, L

IUBMB Life 2012
33372854 SARS-CoV-2 proteases PLpro and 3CLpro cleave IRF3 and critical modulators of inflammatory pathways (NLRP12 and TAB1): implications for disease presentation across species

Moustaqil, M, Jacques, D, Gambin, Y, Rudolffi-Soto, P, Freiberg, AN, Hunter, DJB, Chiu, HP, Bhumkar, A, Lee, B, Van Tol, S, Ollivier, E, Sierecki, E, Stevens, C

Emerg Microbes Infect 2021
Participants
Participates
Catalyst Activity

cysteine-type endopeptidase activity of 3CLp dimer [cytosol]

Disease
Name Identifier Synonyms
COVID-19 DOID:0080600 2019 Novel Coronavirus (2019-nCoV), Wuhan seafood market pneumonia virus infection, 2019-nCoV infection, Wuhan coronavirus infection
Authored
Reviewed
Created
Cite Us!